Dermatophagoides pteronyssinus

DRUG6 trials

Sponsors

Beijing Tongren Hospital, National Biopreparations Center (BIOCEN), National Center of Bioproducts (BIOCEN)

Conditions

Allergic RhinitisAsthmaAsthma.Bronchial asthmaEffects of Immunotherapy

Phase 2

Efficacy of VALERGEN-DP subcutaneous vaccine in asthmatic adults

Active, not recruitingRPCEC00000027

National Biopreparations Center (BIOCEN)Bronchial asthma

Start: 2003-03-17Updated: 2026-03-30

Efficacy of VALERGEN-DP sublingual vaccine in asthmatic adults.

Active, not recruitingRPCEC00000034

National Biopreparations Center (BIOCEN)Bronchial asthma

Start: 2005-09-07Updated: 2026-03-30

Evidence of the clinical efficacy of VALERGEN-DP vaccine in asthmatics

Active, not recruitingRPCEC00000037

National Biopreparations Center (BIOCEN)Bronchial asthma

Start: 2006-05-10Updated: 2026-03-30

Combined sublingual immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II

RecruitingRPCEC00000240

National Center of Bioproducts (BIOCEN)Asthma

Start: 2019-02-07Target: 120Updated: 2026-03-30

Phase 4

Pharmacovigilance-VALERGEN-Asthma

Active, not recruitingRPCEC00000231

National Center of Bioproducts (BIOCEN)Asthma.

Start: 2011-02-01Target: 2108Updated: 2026-03-30

Unknown Phase

Distinct Response of CD4+CD25+Foxp3+ and IL-10-secreting Type I T Regulatory Cells to Cluster Specific Immunotherapy in Allergic Rhinitis Children

CompletedNCT01291381

Beijing Tongren HospitalAllergic Rhinitis, Effects of Immunotherapy

Start: 2009-02-28End: 2010-10-31Updated: 2011-02-08